Price
CHART BY
Frequently asked questions
What is Transmedics Grp's market capitalization?
The market capitalization of Transmedics Grp is $3.00B. Market capitalization is a measure of the total market value of a publicly traded company. It is calculated by multiplying the current stock price by the total number of outstanding shares.
What is Transmedics Grp's Price-to-Earnings (P/E) ratio?
The Price-to-Earnings (P/E) ratio (TTM) for Transmedics Grp is 22.48. This ratio helps investors assess whether a stock is overvalued or undervalued compared to its earnings.
What is the Earnings Per Share (EPS) for Transmedics Grp?
Transmedics Grp's Earnings Per Share (EPS) over the trailing twelve months (TTM) is $3.844. EPS indicates the company's profitability on a per-share basis.
What are the analyst ratings and target price for Transmedics Grp's stock?
Currently, 12 analysts cover Transmedics Grp's stock, with a consensus target price of $97.30. Analyst ratings provide insights into the stock's expected performance.
What is Transmedics Grp's revenue over the trailing twelve months?
Over the trailing twelve months, Transmedics Grp reported a revenue of $668.47M.
What is the EBITDA for Transmedics Grp?
Transmedics Grp's Earnings before interest, taxes, depreciation, and amortization (EBITDA) over the trailing twelve months is $118.03M. EBITDA measures the company's overall financial performance.
What is the free cash flow of Transmedics Grp?
Transmedics Grp has a free cash flow of $79.04M. Free cash flow indicates the cash generated after accounting for cash outflows to support operations and capital assets.
How many employees does Transmedics Grp have, and what sector and industry does it belong to?
Transmedics Grp employs approximately 898 people. It operates in the Health Care sector, specifically within the Medical Specialties industry.
What is the free float of Transmedics Grp's shares?
The free float of Transmedics Grp is 33.34M. Free float refers to the number of shares available for public trading, excluding restricted shares.
Financials
- Market Cap
- $3.00B
- EPS (TTM)
- $3.844
- Free Float
- 33.34M
- P/E ratio (TTM)
- 22.48
- Revenue (TTM)
- $668.47M
- EBITDA (TTM)
- $118.03M
- Free Cashflow (TTM)
- $79.04M
Pricing
- 1D span
- $86.54$89.52
- 52W span
- $60.13$155.73
Analyst Ratings
The price target is $97.30 and the stock is covered by 12 analysts.
Buy
8
Hold
4
Sell
0
Information
TransMedics Group, Inc. operates as a commercial stage medical technology company. The firm engages in the development and commercialization of organ care system platform. It focuses on the preservation of human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation. The company was founded by Waleed H. Hassanein in August 1998 and is headquartered in Andover, MA.
- Employees
- 898
- Industries
- Medical Specialties
- Sector
- Health Care
Identifier
- Primary Ticker
- TMDX
Knockouts
Real-time data from LSX · Fundamentals & EOD data from FactSet